Inventor · Seattle, WA, US

Jens J. Billgren

30Patents
8h-index
29Co-inventors
71Inventor score

Filing activity: Dec 1, 2011 → Dec 16, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US9255154B2 Anti-PCSK9 antibodies and use thereof Physics 32 Active
US9745373B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 18 Active
US10066009B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 14 Active
US10214582B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10179809B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10189895B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10208112B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 12 Active
US10533048B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 11 Active
US10202435B2 Anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 6 Active
US9783602B2 Anti-NGF compositions and use thereof Emerging Cross-Sectional Technologies 2 Active
US10975135B2 Humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 1 Active
US10954285B2 Humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 1 Active
US10913783B2 Humanized anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 1 Active
US10968268B2 Humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 1 Active
US10259885B2 Anti-PCSK9 antibodies and use thereof Physics 1 Active
US9884909B2 Anti-NGF compositions and use thereof Chemistry; Metallurgy 1 Active
US12162936B2 Methods of treatment with anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active
US10981985B2 Anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active
US11938185B2 Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active
US11254741B2 Anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active
US9499611B2 Anti-NGF compositions and use thereof General 0 Revoked
US10899834B2 Anti-PACAP antibodies Emerging Cross-Sectional Technologies 0 Active
US11352409B2 Anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 0 Active
US10344083B2 Anti-NGF compositions and use thereof Emerging Cross-Sectional Technologies 0 Active
US11111289B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.